Deze website maakt gebruik van cookies. We gebruiken cookies om instellingen te onthouden en je bezoek soepeler te laten verlopen. Daarnaast gebruiken we ook cookies voor de verbetering van de website en het verzamelen en analyseren van statistieken. Lees meer over cookies

Inge van der Sluis

Kinderoncoloog
Inge van der Sluis
Inge van der Sluis
--
  • Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL

    • feb. 2024
    • Inge M, van der Sluis, et al
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups

    • sep. 2023
    • Rob, Pieters, et al
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Health-related quality of life and its determinants during and after treatment for paediatric acute lymphoblastic leukaemia: a national, prospective, longitudinal study in the Netherlands

    • jan. 2023
    • Emily R., Schwartz, et al
    • BMJ open
  • Higher incidence of delayed methotrexate clearance in pediatric acute lymphoblastic leukemia patients treated with imatinib

    • jan. 2023
    • Inge, van der Sluis, et al
    • EJC Pediatric Oncology
  • Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis)

    • jan. 2023
    • Aniek, Uittenboogaard, et al
    • Cancer Medicine
Bekijk alle publicaties